Lantheus Holdings, Inc. Revenue Breakdown
No Revenue Breakdown for LNTH on this site yet.
- 2025-12-31: Others Not split by product in the filing$1.54B100.00%; Total revenue $1.54B.
- 2024-12-31: Others Not split by product in the filing$1.53B100.00%; Total revenue $1.53B.
- 2023-12-31: Others Not split by product in the filing$1.30B100.00%; Total revenue $1.30B.
- 2022-12-31: Others Not split by product in the filing$935.06M100.00%; Total revenue $935.06M.
Source checked: the stored Revenue Breakdown page for LNTH.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2025-12-31 | Not split by product in the filing $1.54B 100.00% | $1.54B |
| 2024-12-31 | Not split by product in the filing $1.53B 100.00% | $1.53B |
| 2023-12-31 | Not split by product in the filing $1.30B 100.00% | $1.30B |
| 2022-12-31 | Not split by product in the filing $935.06M 100.00% | $935.06M |
| 2021-12-31 | Not split by product in the filing $425.21M 100.00% | $425.21M |
| 2020-12-31 | Not split by product in the filing $339.41M 100.00% | $339.41M |
| 2019-12-31 | Not split by product in the filing $347.34M 100.00% | $347.34M |
| 2018-12-31 | Not split by product in the filing $343.37M 100.00% | $343.37M |
| 2017-12-31 | Not split by product in the filing $331.38M 100.00% | $331.38M |
| 2016-12-31 | Not split by product in the filing $301.85M 100.00% | $301.85M |
| 2015-12-31 | Not split by product in the filing $293.46M 100.00% | $293.46M |
| 2014-12-31 | Not split by product in the filing $301.60M 100.00% | $301.60M |
| 2013-12-31 | Not split by product in the filing $283.67M 100.00% | $283.67M |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2026-06-30 | Not split by product $388.18M 100.00% | $388.18M |
| 2026-03-31 | Not split by product $377.33M 100.00% | $377.33M |
| 2025-12-31 | Not split by product $406.79M 100.00% | $406.79M |
| 2025-09-30 | Not split by product $384.01M 100.00% | $384.01M |
| 2025-06-30 | Not split by product $378.05M 100.00% | $378.05M |
| 2025-03-31 | Not split by product $372.76M 100.00% | $372.76M |
| 2024-12-31 | Not split by product $391.11M 100.00% | $391.11M |
| 2024-09-30 | Not split by product $378.73M 100.00% | $378.73M |
| 2024-06-30 | Not split by product $394.09M 100.00% | $394.09M |
| 2024-03-31 | Not split by product $369.98M 100.00% | $369.98M |
| 2023-12-31 | Not split by product $354.00M 100.00% | $354.00M |
| 2023-09-30 | Not split by product $319.95M 100.00% | $319.95M |
| 2023-06-30 | Not split by product $321.70M 100.00% | $321.70M |
| 2023-03-31 | Not split by product $300.78M 100.00% | $300.78M |
| 2022-12-31 | Not split by product $263.17M 100.00% | $263.17M |
| 2022-09-30 | Not split by product $239.29M 100.00% | $239.29M |
| 2022-06-30 | Not split by product $223.72M 100.00% | $223.72M |
| 2022-03-31 | Not split by product $208.88M 100.00% | $208.88M |
| 2021-12-31 | Not split by product $129.56M 100.00% | $129.56M |
| 2021-09-30 | Not split by product $102.07M 100.00% | $102.07M |
| 2021-06-30 | Not split by product $101.06M 100.00% | $101.06M |
| 2021-03-31 | Not split by product $92.51M 100.00% | $92.51M |
| 2020-12-31 | Not split by product $94.15M 100.00% | $94.15M |
| 2020-09-30 | Not split by product $88.54M 100.00% | $88.54M |
| 2020-06-30 | Not split by product $66.01M 100.00% | $66.01M |
| 2020-03-31 | Not split by product $90.70M 100.00% | $90.70M |
| 2019-12-31 | Not split by product $89.35M 100.00% | $89.35M |
| 2019-09-30 | Not split by product $85.78M 100.00% | $85.78M |
| 2019-06-30 | Not split by product $85.70M 100.00% | $85.70M |
| 2019-03-31 | Not split by product $86.51M 100.00% | $86.51M |
| 2018-12-31 | Not split by product $86.27M 100.00% | $86.27M |
| 2018-09-30 | Not split by product $88.90M 100.00% | $88.90M |
| 2018-06-30 | Not split by product $85.57M 100.00% | $85.57M |
| 2018-03-31 | Not split by product $82.63M 100.00% | $82.63M |
| 2017-12-31 | Not split by product $81.24M 100.00% | $81.24M |
| 2017-09-30 | Not split by product $79.94M 100.00% | $79.94M |
| 2017-06-30 | Not split by product $88.84M 100.00% | $88.84M |
| 2017-03-31 | Not split by product $81.36M 100.00% | $81.36M |
| 2016-12-31 | Not split by product $74.35M 100.00% | $74.35M |
| 2016-09-30 | Not split by product $73.06M 100.00% | $73.06M |
| 2016-06-30 | Not split by product $77.97M 100.00% | $77.97M |
| 2016-03-31 | Not split by product $76.47M 100.00% | $76.47M |
| 2015-12-31 | Not split by product $71.20M 100.00% | $71.20M |
| 2015-09-30 | Not split by product $74.12M 100.00% | $74.12M |
| 2015-06-30 | Not split by product $73.31M 100.00% | $73.31M |
| 2015-03-31 | Not split by product $74.82M 100.00% | $74.82M |
| 2014-12-31 | Not split by product $76.97M 100.00% | $76.97M |
| 2014-09-30 | Not split by product $75.68M 100.00% | $75.68M |
| 2014-06-30 | Not split by product $75.61M 100.00% | $75.61M |
| 2014-03-31 | Not split by product $73.34M 100.00% | $73.34M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |